First-In-Human (FIH), Single Ascending Dose (SAD) Study of FluoroEthylNorMemantine (FENM)

Clinical trial NCT05921929 · WITHDRAWN

Trial details

NCT number: NCT05921929
Sponsor: ReST Therapeutics
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

PTSD Alzheimer Disease Brain Diseases Neuro-Degenerative Disease Major Depressive Disorder Treatment Resistant Depression

Start date: 2024-05-02
Primary completion: 2024-05-02
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.